NIH-funded research R21 grant

A Hidden Hormone That May Help Preserve Thinking as We Age

Official title: An Overlooked Steroid Hormone as a Driver of Cognitive Resilience

Funded at University of California, San Francisco · NIH-11442545 · Data updated 2026-11-12

A small exploratory study in adults 21+ looks at whether the hormone ADIOL could protect thinking skills as people age, especially in the context of Alzheimer’s risk.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$451,000
NIH project number1R21AG104396-01
Project IDNIH-11442545 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 21 and older who are at risk for Alzheimer’s disease or related dementias, or who are studying cognitive aging.

Less likely to help

People without AD/ADRD risk or cognitive aging concerns may not directly benefit from this exploratory work.

What this research studies

This NIH grant explores whether the steroid hormone ADIOL helps maintain cognitive function in aging adults at risk for Alzheimer's disease. Researchers will use non-human models for initial insight and plan to translate findings toward human studies, with a focus on brain signaling pathways and how ADIOL interacts with ERβ and NMDA-related processes. The goal is to identify if boosting ADIOL can improve learning and memory by modulating brain chemistry linked to aging and dementia. Results could point toward new strategies to support healthy cognitive aging in people at risk for AD/ADRD.

Why it matters

Potential benefit: If successful, this work could guide future therapies to help people maintain memory and thinking skills as they age, particularly for those at risk of Alzheimer’s disease.

How similar studies have gone: Preclinical studies in animals show that ADIOL can influence learning and memory and modulate brain pathways, supporting further investigation in humans.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Ashrafi, Kaveh — University of California, San Francisco
  • Study coordinator: Ashrafi, Kaveh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.